Trait Information | |
Identifier | HP_0002315 |
Description | Cephalgia, or pain sensed in various parts of the head, not confined to the area of distribution of any nerve. [PMID: 15304572] | Trait category |
Neurological disorder
|
Synonyms |
2 synonyms
|
Mapped terms |
3 mapped terms
|
Polygenic Score ID & Name | PGS Publication ID (PGP) | Reported Trait | Mapped Trait(s) (Ontology) | Number of Variants |
Ancestry distribution GWAS Dev Eval |
Scoring File (FTP Link) |
---|---|---|---|---|---|---|
PGS000909 (PRS_Headaches) |
PGP000238 | Campos AI et al. Commun Med (Lond) (2021) |
Headache | Headache | 2,862,172 | - |
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000909/ScoringFiles/PGS000909.txt.gz |
PGS Performance Metric ID (PPM) |
Evaluated Score |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|---|
PPM002940 | PGS000909 (PRS_Headaches) |
PSS001283| European Ancestry| 5,719 individuals |
PGP000238 | Campos AI et al. Commun Med (Lond) (2021) |
Reported Trait: Headaches in Sertraline takers | OR: 1.16 [1.08, 1.25] | — | Variance explained (Nagelkerke's R2*100): 0.49 | sex, age at study enrollment, genetic PCs 1-20 | — |
PPM002941 | PGS000909 (PRS_Headaches) |
PSS001279| European Ancestry| 4,365 individuals |
PGP000238 | Campos AI et al. Commun Med (Lond) (2021) |
Reported Trait: Headaches in Escitalopram takers | OR: 1.06 [0.97, 1.16] | — | Variance explained (Nagelkerke's R2*100): 0.08 | sex, age at study enrollment, genetic PCs 1-20 | — |
PPM002942 | PGS000909 (PRS_Headaches) |
PSS001284| European Ancestry| 3,967 individuals |
PGP000238 | Campos AI et al. Commun Med (Lond) (2021) |
Reported Trait: Headaches in Venlafaxine takers | OR: 1.11 [1.01, 1.21] | — | Variance explained (Nagelkerke's R2*100): 0.22 | sex, age at study enrollment, genetic PCs 1-20 | — |
PPM002943 | PGS000909 (PRS_Headaches) |
PSS001275| European Ancestry| 1,657 individuals |
PGP000238 | Campos AI et al. Commun Med (Lond) (2021) |
Reported Trait: Headaches in Amitriptyline takers | OR: 1.09 [0.93, 1.28] | — | Variance explained (Nagelkerke's R2*100): 0.15 | sex, age at study enrollment, genetic PCs 1-20 | — |
PPM002944 | PGS000909 (PRS_Headaches) |
PSS001281| European Ancestry| 1,987 individuals |
PGP000238 | Campos AI et al. Commun Med (Lond) (2021) |
Reported Trait: Headaches in Mirtazapine takers | OR: 1.04 [0.9, 1.2] | — | Variance explained (Nagelkerke's R2*100): 0.04 | sex, age at study enrollment, genetic PCs 1-20 | — |
PPM002945 | PGS000909 (PRS_Headaches) |
PSS001277| European Ancestry| 2,524 individuals |
PGP000238 | Campos AI et al. Commun Med (Lond) (2021) |
Reported Trait: Headaches in Desvenlafaxine takers | OR: 1.08 [0.98, 1.2] | — | Variance explained (Nagelkerke's R2*100): 0.16 | sex, age at study enrollment, genetic PCs 1-20 | — |
PPM002946 | PGS000909 (PRS_Headaches) |
PSS001276| European Ancestry| 2,585 individuals |
PGP000238 | Campos AI et al. Commun Med (Lond) (2021) |
Reported Trait: Headaches in Citalopram takers | OR: 1.11 [0.98, 1.26] | — | Variance explained (Nagelkerke's R2*100): 0.23 | sex, age at study enrollment, genetic PCs 1-20 | — |
PPM002947 | PGS000909 (PRS_Headaches) |
PSS001280| European Ancestry| 3,670 individuals |
PGP000238 | Campos AI et al. Commun Med (Lond) (2021) |
Reported Trait: Headaches in Fluoxetine takers | OR: 1.02 [0.93, 1.12] | — | Variance explained (Nagelkerke's R2*100): 0.01 | sex, age at study enrollment, genetic PCs 1-20 | — |
PPM002948 | PGS000909 (PRS_Headaches) |
PSS001278| European Ancestry| 1,995 individuals |
PGP000238 | Campos AI et al. Commun Med (Lond) (2021) |
Reported Trait: Headaches in Duloxetine takers | OR: 1.03 [0.92, 1.15] | — | Variance explained (Nagelkerke's R2*100): 0.02 | sex, age at study enrollment, genetic PCs 1-20 | — |
PPM002949 | PGS000909 (PRS_Headaches) |
PSS001282| European Ancestry| 1,580 individuals |
PGP000238 | Campos AI et al. Commun Med (Lond) (2021) |
Reported Trait: Headaches in Paroxetine takers | OR: 1.16 [1.0, 1.35] | — | Variance explained (Nagelkerke's R2*100): 0.46 | sex, age at study enrollment, genetic PCs 1-20 | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS001275 | — | — | [
|
— | European | — | AGDS | — |
PSS001276 | — | — | [
|
— | European | — | AGDS | — |
PSS001277 | — | — | [
|
— | European | — | AGDS | — |
PSS001278 | — | — | [
|
— | European | — | AGDS | — |
PSS001279 | — | — | [
|
— | European | — | AGDS | — |
PSS001280 | — | — | [
|
— | European | — | AGDS | — |
PSS001281 | — | — | [
|
— | European | — | AGDS | — |
PSS001282 | — | — | [
|
— | European | — | AGDS | — |
PSS001283 | — | — | [
|
— | European | — | AGDS | — |
PSS001284 | — | — | [
|
— | European | — | AGDS | — |